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Abstract
Introduction: Metastatic mesothelioma to the oral cavity arises from the pleura or peritoneum and distant
hematogenous metastases are seen in more than half of cases but only a few cases are reported to the oral cavity.
Case: A 75 year old male suffering from metastatic mesothelioma presents an hyperplasia of the attached gingiva.
Malignant mesothelioma is a rare tumour arising from pleura, pericardium or peritoneum.
Conclusion: This article highlights the importance of biopsy and histopathological diagnosis of oral lesions
especially in case of a malignant history.
Keywords: Mesothelioma metastasis, soft tissue
Introduction
Malignant pleural mesothelioma is a malignant neo-
plasm of mesodermal origin and arises from multipo-
tential mesothelial or subserosal cells of the pleura,
pericardium and peritoneum. There are different
forms: epitheloid (60%), sarcomatoid (10-20%) and
biphasic patterns (20-30%). Metastases to the oral cav-
ity are very rare [1,2]. They are more common in the
jaw bones than the soft tissue. The most common sites
for men are the lungs ( 27%), kidneys (13%) and skin
(13%) - for women, the breast (24%) and genital organs
(17%), followed by bone (10%) and kidney (10%) [1].
The reason for this gender-dependent metastatic pat-
tern has not completely been elucidated yet. In 90% of
all pleural mesothelioma, asbestos-association due to
occupational exposure is reported. The tumour is
found in patients in the fifth and sixth decades. The
latency between exposure and manifestation takes
approximately 20-40 years. Occurrence of the malig-
nant disease typically carries an average survival rate of
9-12 months [3].
A patient with a history of malignant pleural mesothe-
lioma with metastatic disease to the attached gingiva is
presented.
Patient
A 75-year-old man was referred from his private dentist
to the Department of Oral Surgery, University of Zurich
with a painless growth of the attached gingiva in the
disto-buccal region of tooth 35. It had been present for
6 weeks and had increased in size during this period of
time.
An epitheloid mesothelioma was diagnosed 2 years
earlier (Figure 1) and treated with chemotherapy. The
patient commenced the drug Alimta
® (Pemetrexed)
with palliative intent. He had had a significant asbestos
exposure during his working life as an electrician. His
medical history was otherwise unremarkable. He was a
non-smoker.
Extraorally, neither swelling nor lymphadenopathy was
discernible. The innervation of the N.trigeminus was
balanced on both sides. Oral examination showed an
exophytic, compact and in parts ulcerous swelling sur-
rounding the premolar tooth 35 (Figure 2). The lesion
measured approximately 1.5 cm by 1.0 cm. The affected
tooth was of grade one mobility, no pathological results
in sensitivity and percussion were found and there was
no objective paraesthesia in the distribution of the left
mental nerve.
Radiological examination (orthopantomogram and
digital volume tomography) of the lower jaw revealed no
destruction of the bony architecture (Figure 3, 4). There
were no changes to the structure of the compacta or
spongiosa.
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mark was carried out under local anaesthesia. The sam-
ple measured 10 × 5 mm including both normal and
modified gingiva. During the biopsy an unusual blood
flow was conspicuous. The second premolar was not
extracted.
Histology and immunohistochemistry confirmed the
diagnosis of a metastasis of the pleural mesothelioma.
Diagnostic considerations
Clinically, soft tissue metastases typically present as ses-
sile or nodular masses that characteristically resemble
hyperplastic reactive lesions, such as pyogenic granu-
loma or giant cell granuloma [4]. Differential diagnosis,
such as other benign tumours of the oral mucosa
including lipoma, myxoma, neurofibroma, schwannoma,
leiomyoma and various forms of epulis, have to be con-
sidered. Murray et al. [5] reported a case where the clin-
ical appearance was most suggestive of a fibroepithelial
polyp localized on the dorsum of the tongue. Therefore,
excisional biopsy of the lesion was arranged to confirm
the diagnosis histologically.
Histology
Grossly, the specimen was a polypous lesion measuring
0,5 × 0,4 cm, protruding from a mucous membrane
spindle with a white cut face.
On microscopy, a submucous infiltrate of a neoplasm
with marked cell atypia and a glandular growth pattern
was seen (Figure 5 & 6).
In comparison, the pleural biopsy taken two years pre-
viously, when malignant mesothelioma was originally
diagnosed in the patient, showed very similar cytology
but a more trabecular architecture with only occasional
tubular formations (Figure 7).
Conventional morphology ruled out clinical differen-
tial diagnoses such as pyogenic granuloma, epulis, drug-
induced gingival hyperplasia or soft tissue tumours.
Figure 1 Chest CT presenting the mesothelioma
Figure 2 Hyperplasia of the attached gingiva showing the soft
tissue metastasis
Figure 3 Orthopantomogram is showing no bony destruction
Figure 4 Digital volume tomography sagittal is showing no
changings in bony architecture
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mesothelioma or adenocarcinoma, primarily of the lung.
Calretinin, a mesothelialm a r k e rt u r n e do u tt ob e
strongly positive in tumour cells on immunohistochem-
ical staining (Figure 8), substantiating diagnosis of an
epitheloid mesothelioma metastasis. Positive staining for
cytokeratins 5/6 and negative staining for Ber-EP4
further helped to distinguish it from adenocarcinoma.
Discussion
Metastases of a malignant mesothelioma are very rare
but have previously been described. An English litera-
ture review (Table 1) revealed six cases on the tongue,
four (including the present report) the attached gingiva,
one case the bone and one the floor of the mouth in
only male patients with a previous diagnosis of mesothe-
lioma. The median age was 61.25 years with a median
time from diagnosis to development of the oral metasta-
sis was 12.4 months.
Metastatic tumours to the oral cavity and jaws are
uncommon lesions and represent about 1% of all
metastases in humans. Primary breast carcinomas are
the most common types of tumour to metastasize to
the jaw bones while primary lung carcinomas are the
most common types of tumour to metastasize to the
oral soft tissue [6]. These oral metastases represent
about 1% of oral malignances and there are more cases
reported arising in the jaw bones than in the oral soft
tissues with a ratio of approximately 2:1 [7]. Most of
the soft tissue metastases occur on the gingiva and
alveolar mucosa, with an additional 27% involving the
tongue. It seems that the presence of teeth has a cru-
cial effect on the oral site preference of metastases. In
Figure 5 Conventional H&E morphology (50× and 100×)
showing squamous mucosa with tubular tumour infiltrates.
Figure 6 Conventional H&E morphology (50× and 100×)
showing squamous mucosa with tubular tumour infiltrates.
Figure 7 Conventional H&E (100×) morphology of pleural
Biopsy taken in 2008 showing an infiltrate with a trabecular
architecture.
Figure 8 Calretinine stain (50×), strong positivity of the
tumour cells for this mesothelial marker.
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the attached gingiva, whereas in edentulous patients,
metastastic lesions were equally distributed between
the tongue and alveolar mucosa [8]. In this case, the
primary tumour was histologically classified as an
epitheloid type. Law et al. reported that the epithelial
type has a tendency to invade directly and cause lym-
phatic metastases similar to carcinoma, whereas the
sarcomatous type tends to metastasize hematogenously
like sarcoma [7].
Only a small number of reports for metastases in the
oral cavity of a malignant pleura mesothelioma were
found in the literature (Table 1). 12 cases were found in
all. The age-range of the male-only patients is 45 - 75.
T h et o n g u e( 6c a s e s )s e e m st ob et h ep r e f e r r e ds i t ef o r
metastases, followed by the attached gingiva (4 cases)
and only 1 case is published which affects either the
lower jaw or the floor of the mouth. One possible expla-
nation for the tendency towards the tongue and the
attached gingiva might be the rich capillary network,
especially where chronically inflamed gingiva trap malig-
nant cells and the fragmented basement membranes of
proliferation capillaries allow easier penetration by
malignant cells than in more mature blood vessels [9].
The tongue also is well vascularized and it has been
p o s t u l a t e dt h a tt h i sm a yp r o v i d eag o o ds e t t i n gf o r
malignant cells [10].
Several differential diagnosis should be taken into con-
sideration. An enlargement or overgrowth of the gingiva
is a recognized complication that has been associated
with the administration of phenytoin, some calcium
channel blockers, and cyclosporine [11]. However, in
most of these cases, hyperplasia is general rather than
localized, although there are still exceptions.
As with the present patient, pemetrexed with a plati-
num agent is the regime of first choice in chemotherapy
for mesothelioma [12]. There are many known side
effects, but no publication was found which describes an
effect to the oral soft tissue.
This article highlights the importance of biopsy and
histopathological diagnosis of oral lesions especially in
case of a malignant history. Furthermore, a regular
screening for oral neoplasms is indispensable. Prognosis
for patients with malignant mesothelioma is very poor.
The majority of patients are incurable and the treatment
is aimed at palliation. Having consulted our patient’s
oncologist, one decided to limit the therapy to regular
recalls and an alteration of the chemotherapy drugs but
to avoid surgical treatment with resection of the tumour
because of reduced life expectancy.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
Table 1 Reported cases of soft tissue metastases in mesothelioma (1993 - 2010)
Case Age at time of
occurence
Sex Previous/existing
diagnosis of
mesothelioma
Site of primary
mesothelioma
time from diagnosis to development
of oral metastasis in months
Localisation Publication
Tongue
1 73 m Yes Pleural 24 right lateral 1993 [13]
2 52 m Yes Pleural 24 right lateral 2003 [14]
3 71 m Yes Pleural 14 right lateral 2003 [15]
4 70 m Yes Pleural 9 left lateral 2005 [4]
5 68 m Yes Pleural 5 anterior
central
2007 [16]
6 46 Yes Pleural 8 dorsum 2010 [5]
attached
gingiva
1 45 m Yes Pleural 12 lingual 36 1993 [13]
2 48 m Yes Pleural 4 regio 35-36 1993 [17]
3 63 m Yes Pleural 11 regio 35
buccal
2002 [8]
4 75 m Yes Pleural 24 regio 35
buccal
2010
current
report
Bone
metastasis
1 53 m Yes Pleural 2 regio 38 2003 [7]
Floor of
mouth
1 71 m Yes Pleural 12 right 2010 [18]
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Page 4 of 5images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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